$ALIM ALIMERA SCIENCES INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ALIMERA SCIENCES INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in ALIMERA SCIENCES INC. Insider overview, share value development, latest insider transactions and email notifications about new events in ALIMERA SCIENCES INC for free.

CIK Number: 0001267602
IRS Number: 200028718
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ALIM
Company Address: 6120 WINDWARD PARKWAY STE 290 ALPHARETTA 30005
Phone number: 6789905740

Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the U.S. and International geographic segments. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. Its products include ILUVIEN and NADPH Oxidase Inhibitors. The company was founded by Daniel C. Myers and David R. Holland on June 4, 2003 and is headquartered in Alpharetta, GA.

Market Capitalization: $75.24M
Prev close: $1.16
Average Daily Volume: 304,397
Days Low: $1.15
Year Low: $1.01
Year High: $5.15

ALIMERA SCIENCES INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
EISWIRTH RICHARD S JRPresident and CEO345,704401,017shares bought: 620,871 / shares sold: -123,535 STRONG BUYMay 01 201918 days ago
Jones John PhilipChief Financial Officer110,229127,866shares bought: 81,033 / shares sold: -7,055 STRONG BUYMay 01 201918 days ago

View all ALIMERA SCIENCES INC insiders.

ALIMERA SCIENCES INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 01 2019ALIMALIMERA SCIENCES I ...EISWIRTH RICHARD S JRPresident and CEOGrantA0.822,5002,061345,704343.2 K to 345.7 K (+0.73 %)
May 01 2019ALIMALIMERA SCIENCES I ...Jones John PhilipChief Financial Off ...GrantA0.821,6331,346110,229108.6 K to 110.2 K (+1.50 %)
Feb 08 2019ALIMALIMERA SCIENCES I ...EISWIRTH RICHARD S JRPresident and CEOPayment of ExerciseF0.9614,83314,240142,104156.9 K to 142.1 K (-9.45 %)
Feb 08 2019ALIMALIMERA SCIENCES I ...EISWIRTH RICHARD S JRPresident and CEOPayment of ExerciseF0.9514,83314,105156,937171.8 K to 156.9 K (-8.64 %)
Feb 06 2019ALIMALIMERA SCIENCES I ...Myers C. DanielDirectorPayment of ExerciseF0.9821,96621,472158,676180.6 K to 158.7 K (-12.16 %)
Feb 06 2019ALIMALIMERA SCIENCES I ...Myers C. DanielDirectorPayment of ExerciseF0.9421,96620,648180,642202.6 K to 180.6 K (-10.84 %)
Feb 05 2019ALIMALIMERA SCIENCES I ...Green KennethChief Scientific Of ...Payment of ExerciseF0.9310,81510,099210,104220.9 K to 210.1 K (-4.90 %)
Feb 05 2019ALIMALIMERA SCIENCES I ...Green KennethChief Scientific Of ...Payment of ExerciseF0.8510,8159,194220,919231.7 K to 220.9 K (-4.67 %)
Jan 31 2019ALIMALIMERA SCIENCES I ...Ashman PhilipChief Operating Off ...Payment of ExerciseF0.8413,25411,13729,89243.1 K to 29.9 K (-30.72 %)
Jan 31 2019ALIMALIMERA SCIENCES I ...Ashman PhilipChief Operating Off ...Payment of ExerciseF0.8213,25410,91343,14656.4 K to 43.1 K (-23.50 %)
Jan 31 2019ALIMALIMERA SCIENCES I ...Holland DavidChief Marketing Off ...Payment of ExerciseF0.849,9838,389146,022156 K to 146 K (-6.40 %)
Jan 31 2019ALIMALIMERA SCIENCES I ...Holland DavidChief Marketing Off ...Payment of ExerciseF0.829,9838,220156,005166 K to 156 K (-6.01 %)
Jan 28 2019ALIMALIMERA SCIENCES I ...Jones John PhilipChief Financial Off ...Payment of ExerciseF0.851,4111,19724,96326.4 K to 25 K (-5.35 %)
Jan 28 2019ALIMALIMERA SCIENCES I ...Jones John PhilipChief Financial Off ...Payment of ExerciseF0.861,4111,21826,37427.8 K to 26.4 K (-5.08 %)
Jan 28 2019ALIMALIMERA SCIENCES I ...Jones John PhilipChief Financial Off ...Payment of ExerciseF0.831,4111,17227,78529.2 K to 27.8 K (-4.83 %)

View all ALIMERA SCIENCES INC insider transactions.